BUY GlaxoSmithKline Pharmaceuticals — Rakesh Bansal, 19 Aug 2026

BUYGlaxoSmithKline Pharmaceuticals Limited

byRakesh BansalHorizon: 1–3 months19 Aug 2026via Zee Business (Live)

Entry₹2,982.5Inferred

Target₹3,700

Stop lossNot given

CMP₹2,958.12d ago

Active-0.82%+25.08%upside left 2 mo left

Follow Rakesh Bansal for new calls(33% target hit, 12 closed calls)Get alerts Watch GLAXO for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 7:16 am IST

11 supporting3 neutral0 opposing

Supports the BUY call (11)

MACD above its signal line — bullish momentum

Technicals · macd·7 Sept · today

Past month's volume 2.4× the prior month's average

Technicals · volume·4 Sept · 3d ago

GSK India Shares Rise Amid Strong FY26 Results and Dividend

NewsGoogle News·18 Aug · 3w ago

GSK India Share Price: शेअर ₹2,758 वर, ₹57 डिव्हिडंड आणि दमदार प्रॉफिटची बातमी

NewsGoogle News·18 Aug · 3w ago

GSK India Share Price: ਨਿਵੇਸ਼ਕਾਂ ਦੀ ਹੋਈ ਮੌਜ! FY26 ਦੇ ਸ਼ਾਨਦਾਰ ਨਤੀਜੇ, **₹57** ਡਿਵੀਡੈਂਡ ਦਾ ਐਲਾਨ

NewsGoogle News·18 Aug · 3w ago

Neutral / worth noting (3)

GSK Pharmaceuticals: Addresses Increased Security Trading Volume

NewsGoogle News·26 Aug · 2w ago

GSK India seeks shareholder approval for MD re-appointment, new director

NewsGoogle News·13 Aug · 3w ago

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY GlaxoSmithKline Pharmaceuticals Limited — Rakesh Bansal

AI Assessment